Immunometabolism: At the Crossroads of Novel Gut-Neural-Cardiorenal Pathophysiological Mechanisms of Disease

Richard Flavell, PhD, FRS, is the Sterling Professor of Immunobiology at Yale University School of Medicine, in New Haven, Connecticut, and an investigator at the Howard Hughes Medical Institute in Bethesda, Maryland. He received his BSc and PhD in biochemistry from the University of Hull, England, and performed postdoctoral work in Amsterdam. Flavell uses transgenic and gene-targeted mice to study innate and adaptive immunity, T-cell tolerance and activation in immunity and autoimmunity, apoptosis and regulation of T-cell differentiation.

John F. Cryan, PhD, is vice president for research and innovation, professor and chair of the Department of Anatomy and Neuroscience and University College Cork in Ireland. He is also a principal investigator in the APC Microbiome Institute. Cryan received a BSc in biochemistry and PhD in pharmacology from the National University of Ireland, Galway, Ireland and was a visiting fellow in the Department of Psychiatry at the University of Melbourne in Australia. He completed postdoctoral fellowships at the University of Pennsylvania and the Scripps Research Institute in La Jolla, California. Cryan's research interests include the neurobiological basis of stress-related neuropsychiatric disorders including depression, anxiety and drug dependence.

Quynh Nhu Dinh, PhD, is a research fellow working in the Centre for Cardiovascular Biology and Disease Research at La Trobe University in Australia. She completed her PhD in pharmacology at Australia’s Monash University, and her thesis examined the roles of inflammation, aging and sex differences in hypertension. Dinh specializes in using mouse models of hypertension and vascular dementia. Her current research focuses on understanding the pathophysiology of hypertension and vascular dementia and also evaluates potential therapeutic interventions. Dinh is co-program manager for the Annual Scientific Meeting of Hypertension Australia and a co-lead for the Australian National Hypertension Taskforce Working Group.